Trials / Withdrawn
WithdrawnNCT01643681
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration
Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- R-Bio · Industry
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with lumbar intervertebral disc degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous Adipose Tissue derived MSCs Transplantation | Into lumbar intervertebral disc infusion of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 4x10e7 cells/1mL |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-03-01
- Completion
- 2015-12-01
- First posted
- 2012-07-18
- Last updated
- 2019-06-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01643681. Inclusion in this directory is not an endorsement.